Olema Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANTX
|
AN2 Therapeutics, Inc. | $1.09 | $60.55 M | -0.81 | 41 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
 CNTA
|
Centessa Pharmaceuticals plc | $15.98 | $884.24 M | -6.2 | 72 | $6.88 M |
 DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.95 | $647.94 M | -2.83 | 126 | $0 |
 FENC
|
Fennec Pharmaceuticals Inc. | $4.80 | $187.43 M | 171.5 | 29 | $21.64 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
|
IRON
|
Disc Medicine, Inc. | $64.76 | $967.11 M | -11.82 | 78 | $0 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LRMR
|
Larimar Therapeutics, Inc. | $7.36 | $611.84 M | -9.99 | 42 | $0 |
|
MLYS
|
Mineralys Therapeutics, Inc. | $13.49 | $652.38 M | -6.03 | 28 | $0 |
|
MOLN
|
Molecular Partners AG | $5.75 | $135.05 M | -2.03 | 167 | $7.04 M |
 NVCT
|
Nuvectis Pharma, Inc. | $7.45 | $116.38 M | -4.5 | 13 | $0 |
 OBIO
|
Orchestra BioMed Holdings, Inc. | $6.24 | $285.59 M | -5.47 | 56 | $2.76 M |
 PEPG
|
PepGen Inc. | $6.81 | $537.15 M | -5.11 | 72 | $0 |
 PHVS
|
Pharvaris N.V. | $23.16 | $843.31 M | -5.8 | 83 | $0 |
 SANA
|
Sana Biotechnology, Inc. | $3.39 | $1.55 B | -4.59 | 328 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.79 | $754.16 M | -3.26 | 124 | $0 |